Coronavirus update for Monday, May 11 as of 2:30 p.m.
Department of Health and Human Services
HHS has announced its allocation plan for the distribution of the prescription drug remdesivir to treat patients with COVID-19. The initial shipments were to Connecticut, Illinois, Iowa, Maryland, Michigan, and New Jersey. The drug is being shipped to state health departments, which will decide how it will be distributed among hospitals.- HHS will base future distribution of remdesivir on hospitals’ active COVID-19 cases. For this reason, it is asking hospitals log on to the COVID-19 Web Portal at https://teletracking.protect.hhs.gov, using the same login information they recently used to provide year-to-date coronavirus-related admissions. Once logged in, hospitals are asked to provide the number of currently hospitalized COVID-19 patients, and of those admissions, the number of currently hospitalized patients requiring placement in an intensive care unit as of May 10 or the date they are submitting this data, up to the submission deadline of 8:00 pm ET on Tuesday, May 12. Hospitals will be asked to provide this information weekly so HHS can adjust to the changing national need for remdesivir. Hospitals will receive additional information about future submissions later this week. Find additional help about HHS’s teletracking portal here.
HHS has announced its Centers for Medicare & Medicaid Services
- CMS has updated its compendium of information about COVID-19 emergency declaration blanket waivers for health care providers. Changes include:
- Expanded ability for hospitals to offer long-term-care services (swing beds) (p. 7).
- Waiving of certain eligibility criteria for sole-community hospitals (p. 10) and Medicare-dependent hospitals (p. 10).
- Reduced training requirements for long-term-care facility and nursing facility feeding assistants (p. 18).
- Expanded scope of responsibilities for occupational therapists, physical therapists, and speech language pathologists working for home health agencies (p. 19).
- Changes in service delivery requirements for end-stage renal dialysis providers (p. 24).
- Life-safety code waivers for hospitals, skilled nursing facilities, and others (p. 26).
CMS Stakeholder Engagement Calls
CMS COVID-19 Office Hours Calls (Tuesdays and Thursdays at 5:00 – 6:00 PM Eastern)
Office Hour Calls provide an opportunity for hospitals, health systems, and providers to ask questions of agency officials regarding CMS’s temporary actions that empower local hospitals and healthcare systems to:
- Increase Hospital Capacity – CMS Hospitals Without Walls;
- Rapidly Expand the Healthcare Workforce;
- Put Patients Over Paperwork; and
- Further Promote Telehealth in Medicare
Tuesday, May 12th at 5:00 – 6:00 PM Eastern
Toll Free Attendee Dial In: 833-614-0820;
Access Passcode: 8968295
Thursday, May 14th at 5:00 – 6:00 PM Eastern
Toll Free Attendee Dial In: 833-614-0820;
Access Passcode: 5688374
Lessons from the Front Lines: COVID-19 (Fridays at 12:30 – 2:00 PM Eastern)
Lessons from the Front Lines calls are a joint effort between CMS Administrator Seema Verma, FDA Commissioner Stephen Hahn, MD, and the White House Coronavirus Task Force. Physicians and other clinicians are invited to share their experience, ideas, strategies, and insights with one another related to their COVID-19 response. There is an opportunity to ask questions of presenters.
This week’s Lessons from the Front Lines:
Friday, May 15th at 12:30 – 2:00 PM Eastern
Toll Free Attendee Dial-In: 877-251-0301;
Access Code: 8983296
Weekly COVID-19 Care Site-Specific Calls
CMS hosts weekly calls for certain types of organizations to provide targeted updates on the agency’s latest COVID-19 guidance. One to two leaders in the field also share best practices with their peers. There is an opportunity to ask questions of presenters if time allows.
Home Health and Hospice (Tuesdays at 3:00 PM Eastern)
Tuesday, May 12th at 3:00 – 3:30 PM Eastern
Toll Free Attendee Dial-In: 833-614-0820;
Access Passcode: 9503927
Nursing Homes (Wednesdays at 4:30 PM Eastern)
Wednesday, May 13th at 4:30 – 5:00 PM Eastern
Toll Free Attendee Dial-In: 833-614-0820;
Access Passcode: 2675207
Dialysis Organizations (Wednesdays at 5:30 PM Eastern)
Wednesday, May 13th at 5:30 – 6:00 PM Eastern
Toll Free Attendee Dial-In: 833-614-0820;
Access Passcode: 6772827
Nurses (Thursdays at 3:00 PM Eastern)
Thursday, May 14th at 3:00 – 3:30 PM Eastern
Toll Free Attendee Dial-In: 833-614-0820;
Access Passcode: 4279137
Past Stakeholder Engagement Calls
Find links to audio versions of past stakeholder calls here.
Centers for Disease Control and Prevention
The CDC has published a list of the 395 hospitals that received payments from $12 billion from the Provider Relief Fund set aside for providers that admitted 100 or more COVID-19 patients through April 10.- The CDC has updated its interim guidance and resources for laboratory professionals working with specimens from persons under investigation for COVID-19.
- The CDC has posted an overview of its SARS-Co-V-2 Sequencing for Public Health Emergency, Epidemiology, and Surveillance (SPHERES) program, a new national genomics consortium to coordinate COVID-19 sequencing across the country.
- The CDC has updated its guidance and resources for COVID-19 contact tracing.
- The CDC has updated its FAQ on COVID-19 and children.
The CDC has published Food and Drug Administration
- The FDA has published a fact sheet on the use of remdesivir.
- The FDA has updated its policy for COVID-19 tests during the public health emergency. The policy, for clinical laboratories, commercial manufacturers, and FDA staff, seeks to help accelerate the availability of COVID-19 tests developed by laboratories and commercial manufacturers.
- The FDA has issued an emergency use authorization (EUA) for the first antigen test to help in the rapid detection of the virus that causes COVID-19.
- The FDA has issued an EUA for a specific commercial system for use by providers for temporary isolation and transport of patients with suspected or confirmed COVID-19.
- The FDA has issued an EUA for emergency use of a specific prescription drug to maintain sedation via continuous infusion in adult patients who require ventilation for COVID-19.
- The FDA has issued EUAs for three specific commercial tests for COVID-19. Find those EUAs here, here, and here.
Department of Labor
- The Department of Labor has provided additional guidance to states on the federal pandemic unemployment compensation program. See its announcement and explanation here and the formal guidance itself here.
Federal Funding Opportunities for Hospitals
- NASH has prepared a document that collects and presents in one place the various new federal funding opportunities for hospitals resulting from legislation addressing the COVID-19 public health emergency. Find that document here.
(To receive this daily update directly, sign up for our mailing list at info@safetynetalliance.org.)
